Analyst Price Targets — AHCO
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 26, 2026 11:22 am | Whit Mayo | Leerink Partners | $12.00 | $9.33 | StreetInsider | AdaptHealth (AHCO) PT Lowered to $12 at Leerink Partners |
| February 25, 2026 1:52 pm | Ben Hendrix | RBC Capital | $13.00 | $8.91 | StreetInsider | RBC Capital on AdaptHealth (AHCO): 'Shares Appear Oversold Following Solid Guidance' |
| November 15, 2024 12:09 pm | David MacDonald | Truist Financial | $12.00 | $9.80 | StreetInsider | AdaptHealth (AHCO) PT Lowered to $12 at Truist Securities |
| November 6, 2024 11:57 am | Eric Coldwell | Robert W. Baird | $14.00 | $9.07 | StreetInsider | AdaptHealth (AHCO) PT Lowered to $14 at Baird |
| September 23, 2024 6:50 am | Eric Coldwell | Robert W. Baird | $16.00 | $11.42 | StreetInsider | Baird Reiterates Outperform Rating on AdaptHealth (AHCO) |
| August 8, 2024 9:31 am | Kevin Caliendo | UBS | $13.00 | $9.53 | StreetInsider | UBS Reiterates Buy Rating on AdaptHealth (AHCO) |
| September 20, 2022 7:27 am | — | Deutsche Bank | $28.00 | $21.81 | Benzinga | Deutsche Bank Maintains Buy on AdaptHealth, Raises Price Target to $28 |
| September 19, 2022 8:16 am | — | Truist Financial | $28.00 | $20.98 | Benzinga | Truist Securities Maintains Buy on AdaptHealth, Raises Price Target to $28 |
| August 10, 2022 7:49 am | — | RBC Capital | $29.00 | $22.24 | Benzinga | RBC Capital Maintains Outperform on AdaptHealth, Raises Price Target to $29 |
| August 10, 2022 4:29 am | — | Leerink Partners | $29.00 | $22.24 | Benzinga | SVB Leerink Maintains Outperform on AdaptHealth, Raises Price Target to $29 |
Latest News for AHCO
AdaptHealth Corp. (AHCO) Presents at J.P. Morgan 2026 Global Leveraged Finance Conference Transcript
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK, Feb. 25, 2026 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of AdaptHealth Corp. (NASDAQ: AHCO) breached their fiduciary duties to shareholders.
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the following upcoming investor conferences: The J.P. Morgan Global Leveraged Finance Conference, being held in Miami,…
AdaptHealth Corp. (AHCO) Q4 2025 Earnings Call Transcript
AdaptHealth Corp. (AHCO) came out with quarterly earnings of $0.27 per share, missing the Zacks Consensus Estimate of $0.34 per share. This compares to earnings of $0.39 per share a year ago.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for AHCO.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.